Cardiol Therapeutics Income Statement (2020-2026) | CRDL

Income Statement Jun2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026
Operating items
Amortization - Intangibles (Quarter)
0.02M
Depreciation & Amortization - Total (Quarter)
0.03M
Research & Development (Quarter)
1.69M2.06M2.80M3.04M3.46M3.90M4.14M3.05M2.59M1.92M2.97M2.47M1.98M2.75M3.03M2.62M1.97M3.48M1.97M3.61M
Wages, Salaries and Other (Quarter)
0.92M
Selling, General & Administrative (Quarter)
3.60M6.01M7.59M4.69M3.78M6.23M2.56M2.71M2.11M3.79M2.93M3.77M3.68M7.62M4.12M3.26M3.57M3.92M3.79M3.47M
Restructuring Costs (Quarter)
1.16M
Operating Expenses (Quarter)
6.48M8.07M10.39M7.73M7.24M10.14M6.70M5.76M4.70M5.71M5.90M6.24M5.66M10.37M7.15M5.87M5.54M7.40M5.76M7.08M
Operating Income (Quarter)
-5.23M-8.07M-10.39M-7.73M-7.24M-10.14M-6.70M-6.24M-5.87M-7.08M
EBIT (Quarter)
-5.23M-8.07M-10.39M-7.73M-7.24M-10.14M-6.70M-6.24M-5.87M-7.08M
Non-operating items
Non Operating Investment Income (Quarter)
1.68M0.68M1.32M1.12M0.05M-0.64M0.29M0.42M-1.34M0.51M0.99M0.00M-1.12M
Interest & Investment Income (Quarter)
0.02M0.03M0.02M0.06M0.15M0.30M0.43M0.40M0.39M0.38M0.33M0.28M0.22M0.15M0.22M0.17M0.13M0.09M0.13M0.15M
Other Non Operating Income (Quarter)
-0.13M0.10M1.49M-1.08M1.33M2.28M-0.39M0.06M-0.62M0.50M-0.46M0.47M0.11M-0.10M1.07M-0.07M-0.62M0.07M-0.22M0.16M
Net income details
EBT (Quarter)
-5.20M-8.05M-10.57M-7.67M-7.09M-9.84M-6.38M-5.96M-5.70M-6.93M
Profit After Tax (Quarter)
-5.34M7.87M-4.96M-7.07M-5.09M-6.11M-40.04M5.24M5.56M-4.42M-5.61M-6.81M4.82M9.33M-5.85M5.78M-6.03M7.24M-5.17M-7.89M
Income from Continuing Operations (Quarter)
-5.20M-8.05M-10.57M-7.67M-7.09M-9.84M-6.38M-5.96M-5.70M-6.93M
Consolidated Net Income (Quarter)
-5.20M-8.05M-10.57M-7.67M-7.09M-9.84M-6.38M-5.96M-5.70M-6.93M
Income towards Parent Company (Quarter)
-5.20M-8.05M-10.57M-7.73M-7.24M-10.14M-6.38M-5.76M-4.70M-5.71M-6.24M-5.66M-10.37M-5.70M-6.08M-7.40M-6.93M
Net Income towards Common Stockholders (Quarter)
-5.20M-8.05M-10.57M-7.73M-7.24M-10.14M-6.38M-5.76M-4.70M-5.71M-6.24M-5.66M-10.37M-5.70M-6.08M-7.40M-6.93M
Additional items
EPS (Basic) (Quarter)
-0.13-0.19-0.24-0.12-0.12-0.16-0.10-0.09-0.07-0.09-0.09-0.08-0.15-0.07-0.07-0.09-0.06
EPS (Diluted) (Quarter)
-0.17-0.27-0.24-0.18-0.17-0.23-0.10-0.09-0.08-0.09-0.10-0.09-0.16-0.08-0.09-0.10-0.08
Shares Outstanding (Quarter)
40.06M43.17M43.22M61.93M61.93M62.34M62.51M64.09M64.11M64.49M64.46M67.26M68.75M69.84M71.57M82.61M82.65M84.73M86.99M108.99M
Shares Outstanding (Diluted) (Quarter)
29.86M29.86M43.22M43.22M43.22M43.22M62.51M62.51M62.51M62.51M64.46M64.46M64.46M64.46M71.57M71.57M71.57M71.57M86.99M86.99M
EBITDA (Quarter)
-5.20M-8.07M-10.39M-7.73M-7.24M-10.14M-6.70M-6.24M-5.87M-7.08M
Interest Expenses (Quarter)
0.20M0.11M